Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://tamzinedbk895532.webdesign96.com/39310886/retaglutide-a-promising-glp-1-receptor-agonist